This is a StreetInsider.com Premium Only Page

(FMTX) – StreetInsider.com Reports

Sep 2, 2022 06:25 AM Credit Suisse Downgrades Forma Therapeutics (FMTX) to Neutral

Sep 2, 2022 06:05 AM H.C. Wainwright Downgrades Forma Therapeutics (FMTX) to Neutral

Sep 2, 2022 05:23 AM UPDATE: Oppenheimer Downgrades Forma Therapeutics (FMTX) to Perform

Sep 2, 2022 03:48 AM Jefferies Downgrades Forma Therapeutics (FMTX) to Hold

Sep 1, 2022 02:28 PM Cantor Fitzgerald Downgrades Forma Therapeutics (FMTX) to Neutral

Sep 1, 2022 08:01 AM Forma Therapeutics (FMTX) Acquired by Novo Nordisk for $20/sh or $1.1B

Sep 1, 2022 07:57 AM Forma Therapeutics Holdings (FMTX) halted, news pending

Aug 5, 2022 07:08 AM Forma Therapeutics Holdings (FMTX) Misses Q2 EPS by 11c

Jul 25, 2022 04:35 PM Forma Therapeutics Holdings (FMTX) Announces Chief Medical Officer Resignation

Jun 30, 2022 07:05 AM Forma Therapeutics Holdings (FMTX) Announces Executive Appoitments

Jun 13, 2022 06:46 AM UPDATE: Cantor Fitzgerald Assumes Forma Therapeutics (FMTX) at Overweight

May 26, 2022 07:09 AM Forma Therapeutics Holdings (FMTX) Highlights Etavopivat Development Expansion and Introduces New Oncology Program from Research Pipeline

May 9, 2022 07:52 AM Forma Therapeutics (FMTX) PT Lowered to $31 at Jefferies

May 6, 2022 07:08 AM Forma Therapeutics Holdings (FMTX) Tops Q1 EPS by 12c

Mar 2, 2022 05:38 AM Forma Therapeutics (FMTX) PT Lowered to $49 at Oppenheimer

Mar 1, 2022 07:13 AM Forma Therapeutics Holdings (FMTX) Misses Q4 EPS by 10c

Jan 13, 2022 07:06 AM Forma Therapeutics Holdings (FMTX) Appoints Arturo Molina to its Board

Dec 16, 2021 07:10 AM Forma Therapeutics' (FMTX) Investigational Olutasidenib in Combination with Azacitidine Yields Durable Complete Remission in Patients with mIDH1 AML

Nov 19, 2021 08:02 AM Bolt Biotherapeutics (BOLT) Announces Changes to its Board of Directors

Nov 12, 2021 01:38 PM Forma Therapeutics (FMTX) PT Lowered to $40 at SVB Leerink

Nov 12, 2021 07:08 AM Forma Therapeutics Holdings (FMTX) Tops Q3 EPS by 5c; Reports Cash and Cash Equivalents of $531.8M

Oct 7, 2021 07:06 AM Forma Therapeutics (FMTX) FT-7051 is Well-tolerated and Demonstrates Evidence of Activity in Initial Results from Ongoing Phase 1 Courage Study in Men with Metastatic Castration-resistant Prostate Can

Aug 13, 2021 07:10 AM Forma Therapeutics Holdings (FMTX) Misses Q2 EPS by 13c

Aug 2, 2021 07:25 AM Craig-Hallum Starts Forma Therapeutics (FMTX) at Buy

Jun 15, 2021 07:30 AM Jefferies Assumes Forma Therapeutics (FMTX) at Buy

Jun 14, 2021 07:08 AM Forma Therapeutics Holdings (FMTX) Names John E. Bishop, Ph.D. CTO

Jun 14, 2021 05:30 AM Forma Therapeutics (FMTX) PT Lowered to $54 at SVB Leerink

Jun 11, 2021 01:35 PM Forma Therapeutics (FMTX) PT Lowered to $54 at SVB Leerink, Following Clinical Business Update

Jun 11, 2021 07:07 AM Forma Therapeutics Holdings (FMTX) New Phase 1 Data on Etavopivat at EHA

May 20, 2021 07:13 AM Forma Therapeutics Holdings (FMTX) to Present Data from Pivotal Phase 2 Trial of Olutasidenib at ASCO

May 14, 2021 07:09 AM Forma Therapeutics Holdings (FMTX) Reports In-Line Q1 EPS

Mar 30, 2021 11:32 AM Forma Therapeutics (FMTX) PT Lowered to $62 at Credit Suisse, Following Clinical Update

Mar 30, 2021 07:24 AM Forma Therapeutics Holdings (FMTX) Tops Q4 EPS by 12c

Mar 30, 2021 07:08 AM Forma Therapeutics Holdings (FMTX) Reports Positive FT-4202 600 mg Multiple Ascending Dose Cohort Data Supporting Doses Being Evaluated in Phase 2/3 Registrational Trial

Feb 17, 2021 06:58 AM Oppenheimer Starts Forma Therapeutics (FMTX) at Outperform

Feb 16, 2021 04:39 PM Lone Pine Capital Enters DoorDash (DASH), Farfetch (FTCH), Fidelity National (FIS) - 13F

Jan 20, 2021 07:07 AM Forma Therapeutics Holdings (FMTX) Reports First Patient Dosed in Phase 1 Clinical Trial Evaluating FT-7051

Jan 11, 2021 07:06 AM Forma Therapeutics (FMTX) Reviews 2020 Highlights and Outlines Key 2021 Milestones

Dec 11, 2020 06:07 AM Forma Therapeutics Holdings (FMTX) Prices 5.3M Share Common Offering at $45.25/Sh

Dec 8, 2020 04:16 PM Forma Therapeutics Holdings (FMTX) Announces Proposed 4.6M Share Common Offering

Dec 8, 2020 01:48 PM Forma Therapeutics Holdings (FMTX) Ramps to Session High

Dec 8, 2020 08:41 AM Forma Therapeutics (FMTX) PT Raised to $65 at SVB Leerink

Dec 8, 2020 06:15 AM Forma Therapeutics (FMTX) PT Raised to $68 at Credit Suisse

Dec 7, 2020 04:40 PM Forma Therapeutics Holdings (FMTX) Highlights Proof-of-Concept Data for Phase 1 Trial of FT-4202

Nov 18, 2020 04:10 PM Cantor Fitzgerald Starts Forma Therapeutics (FMTX) at Overweight

Nov 10, 2020 07:16 AM Forma Therapeutics Holdings (FMTX) Announces FT-4202 Receives Orphan Drug Designation in Europe for Treatment of Sickle Cell Disease

Oct 26, 2020 07:07 AM Forma Therapeutics (FMTX) Announces Positive Top-line Olutasidenib Data From Planned Interim Analysis of Registrational Phase 2 Clinical Trial in Acute Myeloid Leukemia

Sep 23, 2020 12:32 PM Cormorant's Chen Pitches Forma Therapeutics (FMTX) Long at Sohn - Bloomberg

Sep 8, 2020 06:09 AM H.C. Wainwright Starts Forma Therapeutics (FMTX) at Buy

Jul 14, 2020 06:15 AM SVB Leerink Starts Forma Therapeutics (FMTX) at Outperform